Rubius Therapeutics | Red Cell Therapeutics™️ | Home Rubius Therapeutics is realizing the power of red by creating red blood cells and transforming them into cellular medicines. Learn More.
Location: United States, Massachusetts, Cambridge
Employees: 201-500
Total raised: $486M
Founded date: 2013
Investors 2
| Date | Name | Website |
| 17.07.2021 | ARCH Ventu... | archventur... |
| - | EcoR1 Capi... | ecor1cap.c... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 18.07.2018 | IPO | $241M | - |
| 01.03.2018 | - | $100M | - |
| 22.06.2017 | Series B | $120M | - |
| 09.12.2015 | - | $25M | - |
Mentions in press and media 21
| Date | Title | Description | Source |
| 09.11.2021 | Rubius Therapeutics Reports Third Quarter 2021 Financial Res... | U.S. Food and Drug Administration (FDA) Clears Investigational New Drug Application for RTX-224, Rub... | marketscre... |
| 23.02.2021 | Rubius Therapeutics : Reports Fourth Quarter and Full Year 2... | Reported Initial Key Takeaways in January 2021 Showing RTX-240 Stimulates Innate and Adaptive Immuni... | marketscre... |
| 30.06.2020 | Rubius marks milestone in PhI/II as CFO departs; Owkin cl... | → Some of the folks at Rubius Therapeutics weren’t too keen about our lede on the Takeda gene t... | endpts.com... |
| 18.07.2018 | Rubius Therapeutics Raises $241M IPO | Cambridge-based biotech company Rubius Therapeutics has raised $241 million by selling 10.5 million ... | bizjournal... |
| 02.03.2018 | Term Sheet — Friday, March 2 | VIRTUAL $$$ Good morning, Term Sheet readers. Paid Content See how A.I. can protect your enterprise ... | fortune.co... |
| 01.03.2018 | Rubius Therapeutics Closes $100M Financing | Rubius Therapeutics, a Cambridge, MA-based biotechnology company creating a new class of cellular th... | finsmes.co... |
| 01.03.2018 | A startup that's making 'superblood' to treat conditions lik... | Courtesy Rubius Rubius CEO Torben Straight Nissen Advertisement Rubius Therapeutics, a biotech devel... | businessin... |
| 01.03.2018 | Rubius raises $100M in crossover round as cell therapies nea... | Rubius Therapeutics has pulled in another $100 million to fund the advance of its red blood cell the... | fiercebiot... |
| 22.06.2017 | Rubius Therapeutics Snags $120M | CAMBRIDGE, MA, Rubius Therapeutics announced that it has raised $120 million in a highly oversubsc... | vcnewsdail... |
| 21.06.2017 | Rubius Therapeutics Closes $120M Financing | Rubius Therapeutics, a Cambridge, MA-based biotechnology company pioneering the development of a new... | finsmes.co... |
Show more